BioCatalystWatch
TARSWorkspace / TARS / OverviewCompany library
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. (TARS)

Website

Price
Market cap
Next catalystExpected 1H 2027TP-05 — Calliope · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

TP-05

Parasite-specific GABA-Cl channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

IRX-101

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

Parasite-specific GABA-Cl channels

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Parasite-specific GABA-Cl channels

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

TP-05

Parasite-specific GABA-Cl channels

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

IRX-101

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

Gildeuretinol (ALK-001)

PreINDP1P2P3FilingApproved
Upcoming / outlook

TP-05

Parasite-specific GABA-Cl channels

History / paused

Parasite-specific GABA-Cl channels

PreINDP1P2P3FilingApproved
TP-04

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Financing

Source and basis

Ownership and institutions

Status
3M

Market Reaction / Supply Context

Market Structure

TARS PR & News

PR & News

TARS SEC archive